Lilly King has one more chance to medal in her final competition before she retires after failing to qualify for the world championship finals in the 100-meter breaststroke.

Kevin Chouinard: SRB coach Pesic, on Djurisic’s omission: “Djurisic is also the future of Serbian basketball. There was a thought to include him as well, but we have a lot of experienced ...

INDIANAPOLIS — Officials with the Indianapolis Public Schools recently announced that the district will receive more than $10 million from the Lilly Endowment Inc. for a comprehensive literac… ...

If you're in the market for a pole saw to help with trimming the trees around your house, the Bauer one may fit the bill. Here's what owners think.

INDIANAPOLIS, July 24, 2025 /PRNewswire/ -- Eli Lilly and Company (LLY) and Verve Therapeutics, Inc. (VERV) today announced that the tender offer to purchase all of the issued and outstanding ...

“With this collaboration, Lilly gains access to a transformative new drug modality and Gate taps into Lilly’s deep expertise in delivering meaningful therapeutics.

Glen Quayle may only be 23 years old. But the medal-winning pole vaulter has already experienced multiple flavors of life. Growing up on Isle of Man, a self-governing island between Great Britain ...

Eli Lilly is tagging along on actress Kym Whitley’s blockbuster summer in a fresh Zepbound partnership with the “Happy Gilmore 2” star. | On a press tour for upcoming golf comedy movie ...

After a long battle with multiple illnesses Deborah left this life peacefully. She is now in the arms of her Lord. Her husband of 46 years by her ...

Four senators are investigating partnerships between direct-to-consumer telehealth firms and pharma companies for possible violations of kickback laws.

COLORADO SPRINGS, Colo. (KRDO) - A Former track star with The Classical Academy in Colorado Springs is the top woman pole vaulter in the world for athletes under 20 years old.

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin drug strategy.